|58.com||Beijing, Beijing, China|
|Allos Therapeutics||Colorado, United States, Westminster|
|Dada||Firenze, Italy, Toscana|
|Divine Capital Management||China, Guangdong, Shenzhen|
|Growth Circuit||California, San Francisco, United States|
|Hybrid Capital||New York, New York, United States|
|IMM Private Equity||Seoul, Seoul-t'ukpyolsi, South Korea|
|Moxxie Ventures||California, San Francisco, United States|
|Obvious Ventures||California, San Francisco, United States|
|Pepper Group||Australia, New South Wales, North Sydney|
|PICC Property and Casualty||China, Hong Kong, Hong Kong Island|
|Pine Labs||India, Noida, Uttar Pradesh|
|Platform Partners||Houston, Texas, United States|
|Prologis Ventures||California, San Francisco, United States|
|Sarwa Capital||Al Qahirah, Cairo, Egypt|
|Transgene||Alsace, France, Illkirch-graffenstaden|
|VStone||China, Huangpu, Shanghai|
|Xiamen Dingsheng Zhicheng||China, Fujian, Xiamen|
|01 Aug 2015||New York, New York, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.